Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes

被引：30

作者：

Satoh, Chikako ^{[1
,2
]}

Dan, Kazuo ^{[1
]}

Yamashita, Taishi ^{[1
,3
]}

Jo, Risa ^{[1
,3
]}

Tamura, Hideto ^{[1
]}

Ogata, Kiyoyuki ^{[1
]}

机构：

[1] Nippon Med Coll, Div Hematol, Dept Med, Bunkyo Ku, Tokyo 1138603, Japan

[2] Nippon Med Coll, Dept Bioregulat, Tokyo 1138603, Japan

[3] Tokyo Univ Sci, Dept Ind Sci & Technol, Chiba, Japan

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 05期

基金：

日本学术振兴会;

关键词：

Myelodysplastic syndromes; flow cytometry; myeloblasts; CD34; CD45;

D O I：

10.1016/j.leukres.2007.08.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent studies have suggested that flow cytometry (FCM) helps diagnose myelodysplastic syndromes (MDS). However, appropriate FCM diagnostic parameters that are easily reproducible by different examiners remain unclarified. We found that "the Ly/Mbl CD45 ratio (mean fluorescence intensity [MFI] of CD45 on lymphocytes/MFI of CD45 on CD34+ myeloblasts)," "the percentage of CD34+ myeloblasts among all nucleated cells," and "the percentage of CD34+ B-cell precursors among all CD34+ cells" had little interexaminer variability. These parameters can be analyzed from one test tube for three-color FCM, and their analysis in combination can diagnose a certain percentage of low-grade MDS patients. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：699 / 707

页数：9

共 30 条

[1]

[Anonymous], FCM IMMUNOPHE NOTYPI

[2] A practical approach to multicolor flow cytometry for immunophenotyping [J].

Baumgarth, N ;

Roederer, M .

JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 243 (1-2) :77-97

[3] CD34/QBEND10 immunostaining in bone marrow biopsies:: an additional parameter for the diagnosis and classification of myelodysplastic syndromes [J].

Baur, AS ;

Meugé-Moraw, C ;

Schmidt, PM ;

Parlier, V ;

Jotterand, M ;

Delacrétaz, F .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (02) :71-79

[4] Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes [J].

Cherian, S ;

Moore, J ;

Bantly, A ;

Vergilio, JA ;

Klein, P ;

Luger, S ;

Bagg, A .

CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 64B (01) :9-17

[5] Reproducibility of non-specific bronchial challenge in adults: implications for design, analysis and interpretation of clinical and epidemiological studies [J].

Chinn, S ;

Schouten, JP .

THORAX, 2005, 60 (05) :395-400

[6] Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome [J].

Elghetany, MT .

BLOOD, 2002, 99 (01) :391-391

[7]

Gratama JW, 1998, CYTOMETRY, V33, P166, DOI 10.1002/(SICI)1097-0320(19981001)33:2<166::AID-CYTO11>3.0.CO

[8]

2-S

[9]

Kussick SJ, 2003, ARCH PATHOL LAB MED, V127, P1140

[10] APPLICATION OF HIERARCHICAL KAPPA-TYPE STATISTICS IN ASSESSMENT OF MAJORITY AGREEMENT AMONG MULTIPLE OBSERVERS [J].

LANDIS, JR ;

KOCH, GG .

BIOMETRICS, 1977, 33 (02) :363-374

← 1 2 3 →